Presented by: Karen Marzlin and Cynthia Webner

Course Description:
This 3-day course includes sessions 4, 5, and 6 of the Institute of Cardiovascular Excellence and are included in the purchase of this 8-session program. These 3 sessions are offered as a standalone program and may be purchased here.

This 3 day program includes a full day on each of these topics: 1) All Things Coronary Artery Disease and Acute Coronary Syndromes, 2) Everything Heart Failure and Hypertension, and 3) Cardiac Pathophysiology Potpourri: Valvular, Inflammatory, Myopathies, Channelopathies & Obstructive Shock.

Learning Objectives:
Upon completion of this course, the participant will be able to:

All Things Coronary Artery Disease and Acute Coronary Syndromes

• Discuss the physiological basis for coronary artery disease and acute coronary syndromes.
• Review ECG findings specific to the recognition of ACS.
• Compare and contrast treatment strategies for STEMI from treatment strategies for NonST-ACS.
• Review antiplatelet strategies in the treatment of ACS.
• Identify complications in the post myocardial infarction patient.

Everything Heart Failure and HTN

• Differentiate heart failure with reduced LVEF from heart failure with preserved LVEF.
• Describe the NYHA classification system and the ACC/AHA stages of heart failure.
• Recognize heart failure patients through physical assessment and diagnostic results.
• Correlate pharmacological treatment strategies with current evidence-based guidelines.
• Identify non-pharmacological treatment strategies for heart failure with reduced and preserved LVEF.
• Identify hypertension treatment strategies based on the most recent evidence-based guidelines.

Cardiovascular Potpourri

• Correlate the signs and symptoms of valvular heart disease with the associated hemodynamic changes.
• Discuss evidence-based treatment strategies for valvular heart disease.
• Identify pathophysiological changes associated with restrictive, hypertrophic, arrhythmogenic and Takotsubo cardiomyopathies.
• Identify clinical presentation associated with restrictive, hypertrophic, arrhythmogenic and Takotsubo cardiomyopathies.
• Discuss treatment options for the patient with restrictive, hypertrophic, arrhythmogenic and Takotsubo cardiomyopathies.
• Discusses etiology, presentation, and patient management strategies for pericarditis, endocarditis, and myocarditis.
• Correlate clinical assessment findings with obstructive shock states.

Continuing Education:
22.5 hours of continuing education (contact hours) are offered with this program, which includes 2.0 hour of pharmacology CE. CNEA is a provider approved by the California Board of Registered Nursing, provider number 15714.

Course Price:
Click here for course price